Home › Funds › BlackRock Inc › IRD
BlackRock Inc position in IRD
OPUS GENETICS INC · Health Care
Latest position (Q2 2026)3.12M sh
Reported value held$12.81M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 109.32K | $143.21K | New |
| Q4 2024 | 109.72K | $130.57K | Hold |
| Q1 2025 | 108.53K | $106.55K | Reduce |
| Q2 2025 | 46.09K | $43.42K | Reduce |
| Q3 2025 | 46.09K | $76.06K | Hold |
| Q4 2025 | 141.90K | $285.21K | Add |
| Q1 2026 | 147.74K | $672.22K | Add |
| Q2 2026 | 3.12M | $12.81M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IRD
- Balyasny Asset Management 3.09M sh · $12.69M · Q2 2026
- Millennium Management 2.30M sh · $9.46M · Q2 2026
- Marshall Wace 1.95M sh · $8.00M · Q2 2026
- Goldman Sachs Group 1.53M sh · $6.28M · Q2 2026
- Geode Capital Management 1.37M sh · $5.62M · Q2 2026
- Vanguard Group 2.32M sh · $4.67M · Q4 2025
- UBS Group AG 683.89K sh · $2.81M · Q2 2026
- Citadel Advisors 665.66K sh · $2.74M · Q2 2026
- Morgan Stanley 464.90K sh · $1.91M · Q2 2026
- Northern Trust Corp 442.15K sh · $1.82M · Q2 2026
- Two Sigma Investments 253.96K sh · $1.04M · Q2 2026